Cardiovascular complications of type 2 diabetes in youth1

Biochemistry and Cell Biology

Volumn 93, Issue 5, 2015, Pages 496-510

  Kehler, D Scott ^a   Stammers, Andrew N ^a   Susser, Shanel E ^a   Hamm, Naomi C ^a   Kimber, Dustin E ^a   Hlynsky, Michael W ^a   Duhamel, Todd A ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MANITOBA INSTITUTE OF CHILD HEALTH   (Canada)

Author keywords

Cardiovascular disease; Clinical trials; Pathophysiology; Type 2 diabetes mellitus; Youth

Indexed keywords

CARDIOLOGY; HEALTH RISKS;

CARDIO-VASCULAR DISEASE; CLINICAL TRIAL; PATHOPHYSIOLOGY; TYPE 2 DIABETES MELLITUS; YOUTH;

DISEASES;

ADIPOCYTOKINE; CYTOKINE; MICRORNA;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; EPIGENETICS; HUMAN; INFLAMMATION; JUVENILE; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREVALENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASCULAR DISEASE; ADOLESCENT; CHILD; COMPLICATION; METABOLISM; YOUNG ADULT;

ADOLESCENT; CARDIOVASCULAR DISEASES; CHILD; DIABETES MELLITUS, TYPE 2; HUMANS; YOUNG ADULT;

EID: 84984868384     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/bcb-2014-0118     Document Type: Review

References (174)

1. ADVANCE Collaborative Group; Patel A. MacMahon S. Chalmers J. Neal B. Billot L. Woodward M. et al 2008. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. N. Engl. J. Med. 358 (24): 2560-2572. 10.1056/NEJMoa0802987. 18539916.
2. Aguilar M.J. González-Jiménez E. Antelo A. Perona J.S. 2013. Insulin Resistance and Inflammation Markers: Correlations in Obese Adolescents. J. Clin. Nurs. 22 (13-14): 2002-2010. 10.1111/jocn.12034. 23216620.
3. Ajuwon K.M. Spurlock M.E. 2005. Adiponectin Inhibits LPS-Induced NF-ΰB Activation and IL-6 Production and Increases PPARI2 Expression in Adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288 (5): R1220-R1225. 10.1152/ajpregu.00397.2004. 15604306.
4. Altomonte J. Cong L. Harbaran S. Richter A. Xu J. Meseck M. Dong H.H. 2004. Foxo1 Mediates Insulin Action on apoC-III and Triglyceride Metabolism. J. Clin. Invest. 114 (10): 1493-1503. 10.1172/JCI19992. 10.1172/JCI200419992. 15546000.
5. Amed S. Dean H.J. Panagiotopoulos C. Sellers E.A.C. Hadjiyannakis S. Laubscher T.A. et al 2010. Type 2 Diabetes, Medication-Induced Diabetes, and Monogenic Diabetes in Canadian Children: A Prospective National Surveillance Study. Diabetes Care, 33 (4): 786-791. 10.2337/dc09-1013. 20067956.
6. Anavekar N.S. Gans D.J. Berl T. Rohde R.D. Cooper W. Bhaumik A. et al 2004. Predictors of Cardiovascular Events in Patients with Type 2 Diabetic Nephropathy and Hypertension: A Case for Albuminuria. Kidney Int. 66 (S92): S50-S55. 10.1111/j.1523-1755.2004.09213.x.
7. Antuna-Puente B. Feve B. Fellahi S. Bastard. J.-P. 2008. Adipokines: The Missing Link between Insulin Resistance and Obesity. Diabetes Metab. 34 (1): 2-11. 10.1016/j.diabet.2007.09.004. 18093861.
8. Arslanian S.A. 2000. Type 2 Diabetes Mellitus in Children: Pathophysiology and Risk Factors. J. Pediatr. Endocrinol. Metab. 13 (Suppl. 6): 1385-1394. 10.1515/jpem-2000-s612. 11202214.
9. Barnes T.L. Crandell J.L. Bell R.A. Mayer-Davis E.J. Dabelea D. Liese A.D. 2013. Change in DASH Diet Score and Cardiovascular Risk Factors in Youth with Type 1 and Type 2 Diabetes Mellitus: The SEARCH for Diabetes in Youth Study. Nutr. Diabetes, 3: e91. 10.1038/nutd.2013.32. 24126768.
10. Berg A.H. Scherer P.E. 2005. Adipose Tissue, Inflammation, and Cardiovascular Disease. Circ. Res. 96 (9): 939-949. 10.1161/01.RES.0000163635.62927.34. 15890981.
11. Berz J.P.B. Singer M.R. Guo X. Daniels S.R. Moore L.L. 2011. Use of a DASH Food Group Score to Predict Excess Weight Gain in Adolescent Girls in the National Growth and Health Study. Arch. Pediatr. Adolesc. Med. 165 (6): 540-546. 10.1001/archpediatrics.2011.71. 21646587.
12. Bitkin E.C. Boyraz M. TaÅkln N. Akçay A. Ulucan K. Akyol M.B. Akçay T. 2013. Effects of ACE Inhibitors on Insulin Resistance and Lipid Profile in Children with Metabolic Syndrome. J. Clin. Res. Pediatr. Endocrinol. 5 (3): 164-169. 10.4274/Jcrpe.1020. 24072084.
13. Blüher M. 2014. Adipokines-Removing Road Blocks to Obesity and Diabetes Therapy. Mol. Metab. 3 (3): 230-240. 10.1016/j.molmet.2014.01.005. 24749053.
14. Bose K.S.C. Gupta S.K. Vyas P. 2012. Adipocytokine Levels in Genetically High Risk for Type 2 Diabetes in the Indian Population: A Cross-Sectional Study. Exp. Diabetes Res. 2012: 386524. 10.1155/2012/386524. 23213322.
15. Bouchard L. Hivert M.-F. Guay S.-P. St-Pierre J. Perron P. Brisson D. 2012. Placental Adiponectin Gene DNA Methylation Levels Are Associated with Mothers' Blood Glucose Concentration. Diabetes, 61 (5): 1272-1280. 10.2337/db11-1160. 22396200.
16. Bradshaw B. 2002. The Role of the Family in Managing Therapy in Minority Children with Type 2 Diabetes Mellitus. J. Pediatr. Endocrinol. Metab. 15 (Suppl. 1): 547-551. 12017230.
17. Breton C.V. Park C. Siegmund K. Gauderman W.J. Whitfield-Maxwell L. Hodis H.N. et al 2014. NOS1 Methylation and Carotid Artery Intima-Media Thickness in Children. Circ. Cardiovasc. Genet. 7 (2): 116-122. 10.1161/CIRCGENETICS.113.000320. 24622112.
18. Cali A.M.G. De Oliveira A.M. Kim H. Chen S. Reyes-Mugica M. Escalera S. et al 2009. Glucose Dysregulation and Hepatic Steatosis in Obese Adolescents: Is There a Link? Hepatology, 49 (6): 1896-1903. 10.1002/hep.22858. 19434725.
19. Cambuli V.M. Misiu M.C. Incani M. Paderi M. Serpe R. Marras V. et al 2008. Assessment of Adiponectin and Leptin as Biomarkers of Positive Metabolic Outcomes after Lifestyle Intervention in Overweight and Obese Children. J. Clin. Endocrinol. Metab. 93 (8): 3051-3057. 10.1210/jc.2008-0476. 18492759.
20. Canadian Diabetes Association. 2013. Clinical Practices Guidelines Expert Committee. Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
21. Carolan E. Hogan A.E. Corrigan M. Gaotswe G. O'Connell J. Foley N. et al 2014. The Impact of Childhood Obesity on Inflammation, Innate Immune Cell Frequency, and Metabolic MicroRNA Expression. J. Clin. Endocrinol. Metab. 99 (3): E474-E478. 10.1210/jc.2013-3529. 24423308.
22. Cerasola G. Cottone S. Mulè. G. 2010. The Progressive Pathway of Microalbuminuria: From Early Marker of Renal Damage to Strong Cardiovascular Risk Predictor. J. Hypertens. 28 (12): 2357-2369. 20842046.
23. Ceriello A. Motz E. 2004. Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited. Arterioscler. Thromb. Vasc. Biol. 24 (5): 816-823. 10.1161/01.ATV.0000122852.22604.78. 14976002.
24. Chirico V. Cannavò S. Lacquaniti A. Salpietro V. Mandolfino M. Romeo P.D. et al 2013. Prolactin in Obese Children: A Bridge between Inflammation and Metabolic-Endocrine Dysfunction. Clin. Endocrinol. (Oxf.), 79 (4): 537-544. 10.1111/cen.12183. 23445298.
25. Codoñer-Franch P. Boix-García L. Simó-Jordá R. Del Castillo-Villaescusa C. Maset-Maldonado J. Valls-Bellés V. 2010. Is Obesity Associated with Oxidative Stress in Children? Int. J. Pediatr. Obes. 5 (1): 56-63. 10.3109/17477160903055945. 19565402.
26. Codoñer-Franch P. Tavárez-Alonso S. Murria-Estal R. Megías-Vericat J. Tortajada-Girbés M. Alonso-Iglesias E. 2011. Nitric Oxide Production Is Increased in Severely Obese Children and Related to Markers of Oxidative Stress and Inflammation. Atherosclerosis, 215 (2): 475-480. 10.1016/j.atherosclerosis.2010.12.035. 21300354.
27. Constantino M.I. Molyneaux L. Limacher-Gisler F. Al-Saeed A. Luo C. Wu T. et al 2013. Long-Term Complications and Mortality in Young-Onset Diabetes Type 2 Diabetes Is More Hazardous and Lethal than Type 1 Diabetes. Diabetes Care, 36 (12): 3863-3869. 10.2337/dc12-2455. 23846814.
28. Copeland K.C. Zeitler P. Geffner M. Guandalini C. Higgins J. Hirst K. et al 2011. Characteristics of Adolescents and Youth with Recent-Onset Type 2 Diabetes: The TODAY Cohort at Baseline. J. Clin. Endocrinol. Metab. 96 (1): 159-167. 10.1210/jc.2010-1642. 20962021.
29. Copeland K.C. Silverstein J. Moore K.R. Prazar G.E. Raymer T. Shiffman R.N. et al 2013. Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents. Pediatrics, 131 (2): 364-382. 10.1542/peds.2012-3494. 23359574.
30. Corgosinho F.C. de Piano A. Sanches P.L. Campos R.M. Silva P.L. Carnier J. et al 2012. The Role of PAI-1 and Adiponectin on the Inflammatory State and Energy Balance in Obese Adolescents with Metabolic Syndrome. Inflammation, 35 (3): 944-951. 10.1007/s10753-011-9397-2. 22038064.
31. Council on Sports Medicine and Fitness and Council on School Health 2006. Active Healthy Living: Prevention of Childhood Obesity Through Increased Physical Activity. Pediatrics, 117 (5): 1834-1842. 10.1542/peds.2006-0472. 16651347.
32. Cree-Green M. Triolo T.M. Nadeau K.J. 2013. Etiology of Insulin Resistance in Youth with Type 2 Diabetes. Curr. Diab. Rep. 13 (1): 81-88. 10.1007/s11892-012-0341-0. 23135953.
33. Creemers E. Tijsen A. Pinto Y. 2012. Circulating MicroRNAs: Novel Biomarkers and Extracellular Communicators in Cardiovascular Disease? Circ. Res. 110 (3): 483-495. 10.1161/CIRCRESAHA.111.247452. 22302755.
34. D'Adamo E. Caprio. S. 2011. Type 2 Diabetes in Youth: Epidemiology and Pathophysiology. Diabetes Care, 34 (Suppl. 2): S161-S165. 10.2337/dc11-s212. 21525449.
35. Dart A.B. Sellers E.A. Martens P.J. Rigatto C. Brownell M.D. Dean H.J. 2012. High Burden of Kidney Disease in Youth-Onset Type 2 Diabetes. Diabetes Care, 35 (6): 1265-1271. 10.2337/dc11-2312. 22432116.
36. Dart A.B. Martens P.J. Rigatto C. Brownell M.D. Dean H.J. Sellers E.A. 2014. Earlier Onset of Complications in Youth With Type 2 Diabetes. Diabetes Care, 37 (2): 436-443. 10.2337/dc13-0954. 24130346.
37. Dawson K.G. Gomes D. Gerstein H. Blanchard J.F. Kahler K.H. 2002. The Economic Cost of Diabetes in Canada, 1998. Diabetes Care, 25 (8): 1303-1307. 10.2337/diacare.25.8.1303. 12145225.
38. Diabetes Prevention Program (DPP) Research Group 2002. The Diabetes Prevention Program (DPP) Description of Lifestyle Intervention. Diabetes Care, 25 (12): 2165-2171. 10.2337/diacare.25.12.2165. 12453955.
39. DREAM Trial Investigators 2006. Effect of Ramipril on the Incidence of Diabetes. N. Engl. J. Med. 355 (15): 1551-1562. 10.1056/NEJMoa065061. 16980380.
40. Evans J.L. Goldfine I.D. Maddux B.A. Grodsky G.M. 2003. Are Oxidative Stress-Activated Signaling Pathways Mediators of Insulin Resistance and Î-Cell Dysfunction? Diabetes, 52 (1): 1-8. 10.2337/diabetes.52.1.1. 12502486.
41. Fantuzzi G. 2005. Adipose Tissue, Adipokines, and Inflammation. J. Allergy Clin. Immunol. 115 (5): 911-919. 10.1016/j.jaci.2005.02.023. 15867843.
42. Faulkner M.S. Quinn L. Rimmer J.H. Rich B.H. 2005. Cardiovascular Endurance and Heart Rate Variability in Adolescents with Type 1 or Type 2 Diabetes. Biol. Res. Nurs. 7 (1): 16-29. 10.1177/1099800405275202. 15920000.
43. Franks P.W. Hanson R.L. Knowler W.C. Sievers M.L. Bennett P.H. Looker H.C. 2010. Childhood Obesity, Other Cardiovascular Risk Factors, and Premature Death. N. Engl. J. Med. 362 (6): 485-493. 10.1056/NEJMoa0904130. 20147714.
44. García-Cardona M.C. Huang F. García-Vivas J.M. López-Camarillo C. Del Río Navarro B.E. Navarro Olivos E. et al 2014. DNA Methylation of Leptin and Adiponectin Promoters in Children Is Reduced by the Combined Presence of Obesity and Insulin Resistance. Int. J. Obes. 38 (11): 1457-1465. 10.1038/ijo.2014.30. 24549138.
45. Giacco F. Brownlee M. 2010. Oxidative Stress and Diabetic Complications. Circ. Res. 107 (9): 1058-1070. 10.1161/CIRCRESAHA.110.223545. 21030723.
46. Gidding S.S. Palermo R.A. DeLoach S.S. Keith S.W. Falkner B. 2014. Associations of Cardiac Structure with Obesity, Blood Pressure, Inflammation, and Insulin Resistance in African-American Adolescents. Pediatr. Cardiol. 35 (2): 307-314. 10.1007/s00246-013-0777-2. 24096716.
47. Gilardini L. Parati G. Sartorio A. Mazzilli G. Pontiggia B. Invitti C. 2008. Sympathoadrenergic and Metabolic Factors Are Involved in Ambulatory Blood Pressure Rise in Childhood Obesity. J. Hum. Hypertens. 22 (2): 75-82. 10.1038/sj.jhh.1002288. 17882228.
48. Giordano P. Del Vecchio G.C. Cecinati V. Delvecchio M. Altomare M. De Palma F. et al 2011. Metabolic, Inflammatory, Endothelial and Haemostatic Markers in a Group of Italian Obese Children and Adolescents. Eur. J. Pediatr. 170 (7): 845-850. 10.1007/s00431-010-1356-7. 21210148.
49. Goldin A. Beckman J.A. Schmidt A.M. Creager M.A. 2006. Advanced Glycation End Products Sparking the Development of Diabetic Vascular Injury. Circulation, 114 (6): 597-605. 10.1161/CIRCULATIONAHA.106.621854. 16894049.
50. Goossens G.H. Blaak E.E. van Baak M.A. 2003. Possible Involvement of the Adipose Tissue Renin-Angiotensin System in the Pathophysiology of Obesity and Obesity-Related Disorders. Obes. Rev. 4 (1): 43-55. 10.1046/j.1467-789X.2003.00091.x. 12608526.
51. Gu W. Huang Y. Zhang Y. Hong J. Liu Y. Zhan W. et al 2014. Adolescents and Young Adults with Newly Diagnosed Type 2 Diabetes Demonstrate Greater Carotid Intima-Media Thickness than Those with Type 1 Diabetes. Diabet. Med. 31 (1): 84-91. 10.1111/dme.12335. 24112039.
52. Gungor N. Arslanian S. 2004. Progressive Beta Cell Failure in Type 2 Diabetes Mellitus of Youth. J. Pediatr. 144 (5): 656-659. 10.1016/j.jpeds.2003.12.045. 15127006.
53. Gungor N. Thompson T. Sutton-Tyrrell K. Janosky J. Arslanian S. 2005. Early Signs of Cardiovascular Disease in Youth With Obesity and Type 2 Diabetes. Diabetes Care, 28 (5): 1219-1221. 10.2337/diacare.28.5.1219. 15855596.
54. Gusso S. Hofman P. Lalande S. Cutfield W. Robinson E. Baldi J.C. 2008. Impaired Stroke Volume and Aerobic Capacity in Female Adolescents with Type 1 and Type 2 Diabetes Mellitus. Diabetologia, 51 (7): 1317-1320. 10.1007/s00125-008-1012-1. 18446317.
55. Handy D.E. Castro R. Loscalzo J. 2011. Epigenetic Modifications: Basic Mechanisms and Role in Cardiovascular Disease. Circulation, 123 (19): 2145-2156. 10.1161/CIRCULATIONAHA.110.956839. 21576679.
56. Hotamisligil G.S. Spiegelman B.M. 1994. Tumor Necrosis Factor Î: A Key Component of the Obesity-Diabetes Link. Diabetes, 43 (11): 1271-1278. 10.2337/diab.43.11.1271. 7926300.
57. Houde A.-A. Guay S.-P. Desgagné V. Hivert M.-F. Baillargeon J.-P. St-Pierre J. et al 2013. Adaptations of Placental and Cord Blood ABCA1 DNA Methylation Profile to Maternal Metabolic Status. Epigenetics, 8 (12): 1289-1302. 10.4161/epi.26554. 24113149.
58. Hung M.-J. Cherng W.-J. Hung M.-Y. Wu H.-T. Pang J.-H.S. 2010. Interleukin-6 Inhibits Endothelial Nitric Oxide Synthase Activation and Increases Endothelial Nitric Oxide Synthase Binding to Stabilized Caveolin-1 in Human Vascular Endothelial Cells. J. Hypertens. 28 (5): 940-951. 10.1097/HJH.0b013e32833992ef. 20375905.
59. Ismail-Beigi F. Craven T. Banerji M.A. Basile J. Calles J. Cohen R.M. et al 2010. Effect of Intensive Treatment of Hyperglycaemia on Microvascular Outcomes in Type 2 Diabetes: An Analysis of the ACCORD Randomised Trial. Lancet, 376 (9739): 419-430. 10.1016/S0140-6736(10)60576-4. 20594588.
60. Jetton T.L. Lausier J. LaRock K. Trotman W.E. Larmie B. Habibovic A. et al 2005. Mechanisms of Compensatory Î-Cell Growth in Insulin-Resistant Rats Roles of Akt Kinase. Diabetes, 54 (8): 2294-2304. 10.2337/diabetes.54.8.2294. 16046294.
61. Kahn S.E. Beard J.C. Schwartz M.W. Ward W.K. Ding H.L. Bergman R.N. Taborsky G.J. Porte D. 1989. Increased Î-Cell Secretory Capacity as Mechanism for Islet Adaptation to Nicotinic Acid-Induced Insulin Resistance. Diabetes, 38 (5): 562-568. 10.2337/diab.38.5.562. 2653928.
62. Kahn S.E. Hull R.L. Utzschneider K.M. 2006. Mechanisms Linking Obesity to Insulin Resistance and Type 2 Diabetes. Nature, 444 (7121): 840-846. 10.1038/nature05482. 17167471.
63. Kalupahana N.S. Moustaid-Moussa N. 2012. The Renin-Angiotensin System: A Link between Obesity, Inflammation and Insulin Resistance. Obes. Rev. 13 (2): 136-149. 10.1111/j.1467-789X.2011.00942.x. 22034852.
64. Kelishadi R. Hashemi M. Mohammadifard N. Asgary S. Khavarian N. 2008. Association of Changes in Oxidative and Proinflammatory States with Changes in Vascular Function after a Lifestyle Modification Trial among Obese Children. Clin. Chem. 54 (1): 147-153. 10.1373/clinchem.2007.089953. 17998270.
65. Kelly A.S. Wetzsteon R.J. Kaiser D.R. Steinberger J. Bank A.J. Dengel D.R. 2004. Inflammation, Insulin, and Endothelial Function in Overweight Children and Adolescents: The Role of Exercise. J. Pediatr. 145 (6): 731-736. 10.1016/j.jpeds.2004.08.004. 15580192.
66. Kim N.H. Pavkov M.E. Knowler W.C. Hanson R.L. Weil E.J. Curtis J.M. et al 2010. Predictive Value of Albuminuria in American Indian Youth With or Without Type 2 Diabetes. Pediatrics, 125 (4): e844-e851. 10.1542/peds.2009-1230. 20194283.
67. Klein R. Klein B.E. Moss S.E. Davis M.D. DeMets D.L. 1984. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV. Diabetic Macular Edema. Ophthalmology, 91 (12): 1464-1474. 10.1016/S0161-6420(84)34102-1. 6521986.
68. Klein R. Klein B.E. Moss S.E. 1992. Epidemiology of Proliferative Diabetic Retinopathy. Diabetes Care, 15 (12): 1875-1891. 10.2337/diacare.15.12.1875. 1464243.
69. Kofler S. Nickel T. Weis M. 2005. Role of Cytokines in Cardiovascular Diseases: A Focus on Endothelial Responses to Inflammation. Clin. Sci. (Lond.), 108 (3): 205-213. 10.1042/CS20040174. 15540988.
70. Koskinen J. Magnussen C.G. Sabin M.A. Kähönen M. Hutri-Kähönen N. Laitinen T. et al 2014. Youth Overweight and Metabolic Disturbances in Predicting Carotid Intima-Media Thickness, Type 2 Diabetes, and Metabolic Syndrome in Adulthood: The Cardiovascular Risk in Young Finns Study. Diabetes Care, 37 (7): 1870-1877. 10.2337/dc14-0008. 24742659.
71. Kriska A. Delahanty L. Edelstein S. Amodei N. Chadwick J. Copeland K. et al 2013. Sedentary Behavior and Physical Activity in Youth With Recent Onset of Type 2 Diabetes. Pediatrics, 131 (3): e850-e856. 10.1542/peds.2012-0620. 23400602.
72. Le P.T. Huisingh C.E. Ashraf A.P. 2013. Glycemic Control and Diabetic Dyslipidemia in Adolescents with Type 2 Diabetes. Endocr. Pract. 19 (6): 972-979. 10.4158/EP13016.OR. 23807519.
73. Lee S. Bacha F. Hannon T. Kuk J.L. Boesch C. Arslanian S. 2012. Effects of Aerobic Versus Resistance Exercise Without Caloric Restriction on Abdominal Fat, Intrahepatic Lipid, and Insulin Sensitivity in Obese Adolescent Boys: A Randomized, Controlled Trial. Diabetes, 61 (11): 2787-2795. 10.2337/db12-0214. 22751691.
74. Liberman J.N. Berger J.E. Lewis M. 2009. Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents. Arch Pediatr Adolesc Med. 163 (4): 357-364. 10.1001/archpediatrics.2009.5. 19349565.
75. Liese A.D. Bortsov A. Günther A.L.B. Dabelea D. Reynolds K. Standiford D.A. Liu L. et al 2011 a. Association of DASH Diet With Cardiovascular Risk Factors in Youth With Diabetes Mellitus The SEARCH for Diabetes in Youth Study. Circulation. 123 (13): 1410-1417. 10.1161/CIRCULATIONAHA.110.955922. 21422385.
76. Magge S.N. 2012. Cardiovascular Risk in Children and Adolescents with Type 1 and Type 2 Diabetes Mellitus. Curr. Cardiovasc. Risk Rep. 6 (6): 591-600. 10.1007/s12170-012-0274-9. 23293697.
77. Magnussen C.G. Koskinen J. Juonala M. Chen W. Srinivasan S.R. Sabin M.A. Thomson R. et al 2012. A Diagnosis of the Metabolic Syndrome in Youth That Resolves by Adult Life Is Associated With a Normalization of High Carotid Intima-Media Thickness and Type 2 Diabetes Mellitus Risk: The Bogalusa Heart and Cardiovascular Risk in Young Finns Studies. J. Am. Coll. Cardiol. 60 (17): 1631-1639. 10.1016/j.jacc.2012.05.056. 23021330.
78. Makino K. Jinnin M. Kajihara I. Honda N. Sakai K. Masuguchi S. Fukushima S. Inoue Y. Ihn H. 2012. Circulating miR-142-3p Levels in Patients with Systemic Sclerosis. Clin. Exp. Dermatol. 37 (1): 34-39. 10.1111/j.1365-2230.2011.04158.x. 21883400.
79. Makni E. Moalla W. Benezzeddine-Boussaidi L. Lac G. Tabka Z. Elloumi M. 2013. Correlation of Resistin with Inflammatory and Cardiometabolic Markers in Obese Adolescents with and without Metabolic Syndrome. Obes. Facts, 6 (4): 393-404. 10.1159/000354574. 23970148.
80. Mangge H. Almer G. Haj-Yahya S. Pilz S. Gasser R. Möller R. Horejsi R. 2008. Preatherosclerosis and Adiponectin Subfractions in Obese Adolescents. Obesity (Silver Spring), 16 (12): 2578-2584. 10.1038/oby.2008.439. 18846045.
81. Matthews D.R. Stratton I.M. Aldington S.J. Holman R.R. Kohner E.M.; UK Prospective Diabetes Study Group. 2004. Risks of Progression of Retinopathy and Vision Loss Related to Tight Blood Pressure Control in Type 2 Diabetes Mellitus: UKPDS 69. Arch. Ophthalmol. 122 (11): 1631-1640. 10.1001/archopht.122.11.1631. 15534123.
82. Mayer-Davis E.J. Davis C. Saadine J. D'Agostino R.B. Dabelea D. Dolan L. et al 2012. Diabetic Retinopathy in the SEARCH for Diabetes in Youth Cohort: A Pilot Study. Diabet. Med. 29 (9): 1148-1152. 10.1111/j.1464-5491.2012.03591.x. 22269205.
83. McGavock J. Sellers E. Dean H. 2007. Physical Activity for the Prevention and Management of Youth-Onset Type 2 Diabetes Mellitus: Focus on Cardiovascular Complications. Diab. Vasc. Dis. Res. 4 (4): 305-310. 10.3132/dvdr.2007.057. 18158700.
84. McGavock J. Dart A. Wicklow B. 2015. Lifestyle Therapy for the Treatment of Youth with Type 2 Diabetes. Curr. Diab. Rep. 15 (1): 568. 10.1007/s11892-014-0568-z. 25398207.
85. McGrath N.M. Parker G.N. Dawson P. 1999. Early Presentation of Type 2 Diabetes Mellitus in Young New Zealand Maori. Diabetes Res. Clin. Pract. 43 (3): 205-209. 10.1016/S0168-8227(99)00003-0. 10369431.
86. Miao F. Gonzalo I.G. Lanting L. Natarajan R. 2004. In Vivo Chromatin Remodeling Events Leading to Inflammatory Gene Transcription under Diabetic Conditions. J. Biol. Chem. 279 (17): 18091-18097. 10.1074/jbc.M311786200. 14976218.
87. Monzillo L.U. Hamdy O. Horton E.S. Ledbury S. Mullooly C. Jarema C. et al 2003. Effect of Lifestyle Modification on Adipokine Levels in Obese Subjects with Insulin Resistance. Obes. Res. 11 (9): 1048-1054. 10.1038/oby.2003.144. 12972674.
88. Moore L.L. Bradlee M.L. Singer M.R. Qureshi M.M. Buendia J.R. Daniels S.R. 2012. Dietary Approaches to Stop Hypertension (DASH) Eating Pattern and Risk of Elevated Blood Pressure in Adolescent Girls. Br. J. Nutr. 108 (9): 1678-1685. 10.1017/S000711451100715X. 22243687.
89. Mora-Fernández C. Domínguez-Pimentel V. de Fuentes M.M. Górriz J.L. Martínez-Castelao A. Navarro-González J.F. 2014. Diabetic Kidney Disease: From Physiology to Therapeutics. J. Physiol. 592 (18): 3997-4012. 10.1113/jphysiol.2014.272328. 24907306.
90. Nadeau K.J. Zeitler P.S. Bauer T.A. Brown M.S. Dorosz J.L. Draznin B. et al 2009. Insulin Resistance in Adolescents with Type 2 Diabetes Is Associated with Impaired Exercise Capacity. J. Clin. Endocrinol. Metab. 94 (10): 3687-3695. 10.1210/jc.2008-2844. 19584191.
91. Narasimhan S. Weinstock R.S. 2014. Youth-Onset Type 2 Diabetes Mellitus: Lessons Learned From the TODAY Study. Mayo Clin. Proc. 8 (6): 806-816. 10.1016/j.mayocp.2014.01.009. 24702733.
92. Nassis G.P. Papantakou K. Skenderi K. Triandafillopoulou M. Kavouras S.A. Yannakoulia M. Chrousos G.P. Sidossis L.S. 2005. Aerobic Exercise Training Improves Insulin Sensitivity without Changes in Body Weight, Body Fat, Adiponectin, and Inflammatory Markers in Overweight and Obese Girls. Metabolism, 54 (11): 1472-1479. 10.1016/j.metabol.2005.05.013. 16253636.
93. Naylor L.H. Green D.J. Jones T.W. Kalic R.J. Suriano K.L. Shah M. et al 2011. Endothelial Function and Carotid Intima-Medial Thickness in Adolescents with Type 2 Diabetes Mellitus. J. Pediatr. 159 (6): 971-974. 10.1016/j.jpeds.2011.05.019. 21722916.
94. Nguyen T.T. Jayadeva V. Cizza G. Brown R.J. Nandagopal R. Rodriguez L.M. Rother K.I. 2014. Challenging Recruitment of Youth With Type 2 Diabetes Into Clinical Trials. J. Adolesc. Health, 54 (3): 247-254. 10.1016/j.jadohealth.2013.08.017. 24161585.
95. Ohashi K. Parker J.L. Ouchi N. Higuchi A. Vita J.A. Gokce N. et al 2010. Adiponectin Promotes Macrophage Polarization toward an Anti-Inflammatory Phenotype. J. Biol. Chem. 285 (9): 6153-6160. 10.1074/jbc.M109.088708. 20028977.
96. Ola M.S. Nawaz M.I. Siddiquei M.M. Al-Amro S. Abu El-Asrar A.M. 2012. Recent Advances in Understanding the Biochemical and Molecular Mechanism of Diabetic Retinopathy. J. Diabetes Complications, 26 (1): 56-64. 10.1016/j.jdiacomp.2011.11.004. 22226482.
97. Ouchi N. Kihara S. Arita Y. Nishida M. Matsuyama A. Okamoto Y. et al 2001. Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages. Circulation, 103 (8): 1057-1063. 10.1161/01.CIR.103.8.1057. 11222466.
98. Paneni F. Costantino S. Volpe M. Lüscher T.F. Cosentino F. 2013. Epigenetic Signatures and Vascular Risk in Type 2 Diabetes: A Clinical Perspective. Atherosclerosis 230 (2): 191-197. 10.1016/j.atherosclerosis.2013.07.003.
99. Pavkov M.E. Bennett P.H. Knowler W.C. Krakoff J. Sievers M.L. Nelson R.G. 2006. Effect of Youth-Onset Type 2 Diabetes Mellitus on Incidence of End-Stage Renal Disease and Mortality in Young and Middle-Aged Pima Indians. JAMA, 296 (4): 421-426. 10.1001/jama.296.4.421. 16868300.
100. Pinhas-Hamiel O. Levy-Shraga Y. 2013. Eating Disorders in Adolescents with Type 2 and Type 1 Diabetes. Curr. Diab. Rep. 13 (2): 289-297. 10.1007/s11892-012-0355-7. 23266564.
101. Pinhas-Hamiel O. Zeitler P. 2005. The Global Spread of Type 2 Diabetes Mellitus in Children and Adolescents. J. Pediatr. 146 (5): 693-700. 10.1016/j.jpeds.2004.12.042. 15870677.
102. Pinhas-Hamiel O. Zeitler P. 2007 a. Acute and Chronic Complications of Type 2 Diabetes Mellitus in Children and Adolescents. Lancet, 369 (9575): 1823-1831. 10.1016/S0140-6736(07)60821-6. 17531891.
103. Pinhas-Hamiel O. Zeitler P. 2007 b. Clinical Presentation and Treatment of Type 2 Diabetes in Children. Pediatr. Diabetes, 8: 16-27. 10.1111/j.1399-5448.2007.00330.x. 17991129.
104. Pinhas-Hamiel O. Standiford D. Hamiel D. Dolan L.M. Cohen R. Zeitler P.S. 1999. The Type 2 Family: A Setting for Development and Treatment of Adolescent Type 2 Diabetes Mellitus. Arch. Pediatr. Adolesc. Med. 153 (10): 1063-1067. 10.1001/archpedi.153.10.1063. 10520614.
105. Pinto T.E. Gusso S. Hofman P.L. Derraik J.G.B. Hornung T.S. Cutfield W.S. Baldi J.C. 2014. Systolic and Diastolic Abnormalities Reduce the Cardiac Response to Exercise in Adolescents With Type 2 Diabetes. Diabetes Care, 37 (5): 1439-1446. 10.2337/dc13-2031. 24574351.
106. Prats-Puig A. Ortega F.J. Mercader J.M. Moreno-Navarrete J.M. Moreno M. Bonet N. et al 2013. Changes in Circulating microRNAs Are Associated with Childhood Obesity. J. Clin. Endocrinol. Metab. 98 (10): E1655-E1660. 10.1210/jc.2013-1496. 23928666.
107. Prendergast C. Gidding S.S. 2014. Cardiovascular Risk in Children and Adolescents with Type 2 Diabetes Mellitus. Curr. Diab. Rep. 14 (2): 454-462. 10.1007/s11892-013-0454-0. 24402326.
108. Rao A.D. Shah R.V. Garg R. Abbasi S.A. Neilan T.G. Perlstein T.S. et al 2013. Aldosterone and Myocardial Extracellular Matrix Expansion in Type 2 Diabetes Mellitus. Am. J. Cardiol. 112 (1): 73-78. 10.1016/j.amjcard.2013.02.060. 23597770.
109. Reddy M.A. Natarajan R. 2013. Role of Epigenetic Mechanisms in the Vascular Complications of Diabetes. Subcell. Biochem. 61: 435-454. 10.1007/978-94-007-4525-4-19. 23150262.
110. Rhodes E.T. Prosser L.A. Hoerger T.J. Lieu T. Ludwig D.S. Laffel L.M. 2012. Estimated Morbidity and Mortality in Adolescents and Young Adults Diagnosed with Type 2 Diabetes Mellitus. Diabet. Med. 29 (4): 453-463. 10.1111/j.1464-5491.2011.03542.x. 22150528.
111. Ribeiro M.M. Silva A.G. Santos N.S. Guazzelle I. Matos L.N.J. Trombetta I.C. et al 2005. Diet and Exercise Training Restore Blood Pressure and Vasodilatory Responses during Physiological Maneuvers in Obese Children. Circulation, 111 (15): 1915-1923. 10.1161/01.CIR.0000161959.04675.5A. 15837944.
112. Ritenbaugh C. Teufel-Shone N.I. Aickin M.G. Joe J.R. Poirier S. Dillingham D.C. et al 2003. A Lifestyle Intervention Improves Plasma Insulin Levels among Native American High School Youth. Prev. Med. 36 (3): 309-319. 10.1016/S0091-7435(02)00015-4. 12634022.
113. Ritz E. Rychlík I. Locatelli F. Halimi S. 1999. End-Stage Renal Failure in Type 2 Diabetes: A Medical Catastrophe of Worldwide Dimensions. Am. J. Kidney Dis. 34 (5): 795-808. 10.1016/S0272-6386(99)70035-1. 10561134.
114. Roberts C.K. Chen A.K. Barnard R.J. 2007. Effect of a Short-Term Diet and Exercise Intervention in Youth on Atherosclerotic Risk Factors. Atherosclerosis, 191 (1): 98-106. 10.1016/j.atherosclerosis.2006.09.011. 17054960.
115. Rocchini A.P. Katch V.L. Grekin R. Moorehead C. Anderson J. 1986. Role for Aldosterone in Blood Pressure Regulation of Obese Adolescents. Am. J. Cardiol. 57 (8): 613-618. 10.1016/0002-9149(86)90845-3. 3513521.
116. Rodriguez B.L. Fujimoto W.Y. Mayer-Davis E.J. Imperatore G. Williams D.E. Bell R.A. et al 2006. Prevalence of Cardiovascular Disease Risk Factors in U.S. Children and Adolescents with Diabetes: The SEARCH for Diabetes in Youth Study. Diabetes Care, 29 (8): 1891-1896. 10.2337/dc06-0310. 16873798.
117. Roth C.L. Kratz M. Ralston M.M. Reinehr T. 2011. Changes in Adipose-Derived Inflammatory Cytokines and Chemokines after Successful Lifestyle Intervention in Obese Children. Metabolism, 60 (4): 445-452. 10.1016/j.metabol.2010.03.023. 20494373.
118. Rubin D.A. McMurray R.G. Hackney A.C. Harrell J.S. 2011. Relationship between Cardiovascular Risk Factors and Adipokines in Adolescents. Horm. Res. Paediatr. 76 (2): 123-129. 10.1159/000327852. 21701142.
119. Sack M.N. 2002. Tumor Necrosis Factor-Î in Cardiovascular Biology and the Potential Role for Anti-Tumor Necrosis Factor-Î Therapy in Heart Disease. Pharmacol. Ther. 94 (1-2): 123-135. 10.1016/S0163-7258(02)00176-6. 12191598.
120. Samaan M.C. 2013. Management of Pediatric and Adolescent Type 2 Diabetes. Int. J. Pediatr. 2013 (October): e972034. 10.1155/2013/972034. 24260037.
121. Satchell S.C. Tooke J.E. 2008. What Is the Mechanism of Microalbuminuria in Diabetes: A Role for the Glomerular Endothelium? Diabetologia, 51 (5): 714-725. 10.1007/s00125-008-0961-8. 18347777.
122. Schipper H.S. Nuboer R. Prop S. van den Ham H.J. de Boer F.K. Kesmir C. et al 2012. Systemic Inflammation in Childhood Obesity: Circulating Inflammatory Mediators and Activated CD14++ Monocytes. Diabetologia, 55 (10): 2800-2810. 10.1007/s00125-012-2641-y. 22806355.
123. Scott A. Toomath R. Bouchier D. Bruce R. Crook N. Carroll D. et al 2006. First National Audit of the Outcomes of Care in Young People with Diabetes in New Zealand: High Prevalence of Nephropathy in Maori and Pacific Islanders. N. Z. Med. J. 119 (1235): U2015. 16751833.
124. Sellers E.A.C. Dean H.J. 2004. Short-Term Insulin Therapy in Adolescents with Type 2 Diabetes Mellitus. J. Pediatr. Endocrinol. Metab. 17 (11): 1561-1564. 10.1515/JPEM.2004.17.11.1561. 15570994.
125. Sénéchal M. Wicklow B. Wittmeier K. Hay J. MacIntosh A.C. Eskicioglu P. et al 2013. Cardiorespiratory Fitness and Adiposity in Metabolically Healthy Overweight and Obese Youth. Pediatrics, 132 (1): e85-e92. 10.1542/peds.2013-0296. 23796736.
126. Shah A.S. Khoury P.R. Dolan L.M. Ippisch H.M. Urbina E.M. Daniels S.R. Kimball T.R. 2011. The Effects of Obesity and Type 2 Diabetes Mellitus on Cardiac Structure and Function in Adolescents and Young Adults. Diabetologia, 54 (4): 722-730. 10.1007/s00125-010-1974-7. 21085926.
127. Shah R.V. Abbasi S.A. Neilan T.G. Hulten E. Coelho-Filho O. Hoppin A. et al 2013. Myocardial Tissue Remodeling in Adolescent Obesity. J. Am. Heart Assoc. 2 (4): e000279. 10.1161/JAHA.113.000279. 23963758.
128. Shaibi G.Q. Cruz M.L. Ball G.D.C. Weigensberg M.J. Salem G.J. Crespo N.C. Goran M.I. 2006. Effects of Resistance Training on Insulin Sensitivity in Overweight Latino Adolescent Males. Med. Sci. Sports Exerc. 38 (7): 1208-1215. 10.1249/01.mss.0000227304.88406.0f. 16826016.
129. Shatat I.F. Flynn J.T. 2011. Relationships between Renin, Aldosterone, and 24-Hour Ambulatory Blood Pressure in Obese Adolescents. Pediatr. Res. 69 (4): 336-340. 10.1203/PDR.0b013e31820bd148. 21178817.
130. Shibata R. Ouchi N. Ito M. Kihara S. Shiojima I. Pimentel D.R. et al 2004. Adiponectin-Mediated Modulation of Hypertrophic Signals in the Heart. Nat. Med. 10 (12): 1384-1389. 10.1038/nm1137. 15558058.
131. Singh S. Loke Y.K. Furberg C.D. 2007. Long-Term Risk of Cardiovascular Events with Rosiglitazone: A Meta-Analysis. JAMA, 298 (10): 1189-1195. 10.1001/jama.298.10.1189. 17848653.
132. Song L. Lin C. Gong H. Wang C. Liu L. Wu J. Tao S. et al 2013. miR-486 Sustains NF-ΰB Activity by Disrupting Multiple NF-ΰB-Negative Feedback Loops. Cell Res. 23 (2): 274-289. 10.1038/cr.2012.174. 23247627.
133. Srinivasan S. Ambler G.R. Baur L.A. Garnett S.P. Tepsa M. Yap F. et al 2006. Randomized, Controlled Trial of Metformin for Obesity and Insulin Resistance in Children and Adolescents: Improvement in Body Composition and Fasting Insulin. J. Clin. Endocrinol. Metab. 91 (6): 2074-2080. 10.1210/jc.2006-0241. 16595599.
134. Stelzer I. Zelzer S. Raggam R.B. Prüller F. Truschnig-Wilders M. Meinitzer A. et al 2012. Link between Leptin and Interleukin-6 Levels in the Initial Phase of Obesity Related Inflammation. Transl. Res. 159 (2): 118-124. 10.1016/j.trsl.2011.10.001. 22243796.
135. Stumvoll M. Goldstein B.J. van Haeften T.W. 2005. Type 2 Diabetes: Principles of Pathogenesis and Therapy. Lancet, 365 (9467): 1333-1346. 10.1016/S0140-6736(05)61032-X. 15823385.
136. Su S.-C. Pei D. Hsieh C.-H. Hsiao F.-C. Wu C.-Z. Hung Y.-J. 2011. Circulating pro-Inflammatory Cytokines and Adiponectin in Young Men with Type 2 Diabetes. Acta Diabetol. 48 (2): 113-119. 10.1007/s00592-009-0171-y. 20058158.
137. Su S. Zhu H. Xu X. Wang X. Dong Y. Kapuku G. et al 2014. DNA Methylation of the LY86 Gene Is Associated with Obesity, Insulin Resistance, and Inflammation. Twin Res. Hum. Genet. 17 (3): 183-191. 10.1017/thg.2014.22. 24735745.
138. Tam W.H. Ma R.C.W. Yang X. Li A.M. Ko G.T.C. Kong A.P.S. et al 2010. Glucose Intolerance and Cardiometabolic Risk in Adolescents Exposed to Maternal Gestational Diabetes: A 15-Year Follow-up Study. Diabetes Care, 33 (6): 1382-1384. 10.2337/dc09-2343. 20215448.
139. Tieh P. Dreimane D. 2014. Type 2 Diabetes Mellitus in Children and Adolescents. Indian J. Pediatr. 81 (2): 165-169. 10.1007/s12098-013-1193-6. 24026917.
140. TODAY Study Group; Zeitler P. Epstein L. Grey M. Hirst K. Kaufman F. Tamborlane W. Wilfley D. 2007. Treatment Options for Type 2 Diabetes in Adolescents and Youth: A Study of the Comparative Efficacy of Metformin Alone or in Combination with Rosiglitazone or Lifestyle Intervention in Adolescents with Type 2 Diabetes. Pediatr. Diabetes, 8 (2): 74-87. 10.1111/pedi.12119. 17448130.
141. TODAY Study Group. Zeitler P. Hirst K. Pyle L. Linder B. Copeland K. Arslanian S. et al 2012. A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 Diabetes. N. Engl. J. Med. 366 (24): 2247-2256. 10.1056/NEJMoa1109333. 22540912.
142. TODAY Study Group. 2013 a. Lipid and Inflammatory Cardiovascular Risk Worsens over 3 Years in Youth with Type 2 Diabetes: The TODAY Clinical Trial. Diabetes Care, 36 (6): 1758-1764. 10.2337/dc12-2388. 23704675.
143. TODAY Study Group. 2013 b. Rapid Rise in Hypertension and Nephropathy in Youth with Type 2 Diabetes: The TODAY Clinical Trial. Diabetes Care, 36 (6): 1735-1741. 10.2337/dc12-2420. 23704672.
144. TODAY Study Group. 2013 c. Effects of Metformin, Metformin plus Rosiglitazone, and Metformin plus Lifestyle on Insulin Sensitivity and Î-Cell Function in TODAY. Diabetes Care, 36 (6): 1749-1757. 10.2337/dc12-2393. 23704674.
145. TODAY Study Group. 2013 d. Safety and Tolerability of the Treatment of Youth-Onset Type 2 Diabetes: The TODAY Experience. Diabetes Care, 36 (6): 1765-1771. 10.2337/dc12-2390. 23704676.
146. TODAY Study Group. 2013 e. Retinopathy in Youth With Type 2 Diabetes Participating in the TODAY Clinical Trial. Diabetes Care, 36 (6): 1772-1774. 10.2337/dc12-2387. 23704677.
147. TODAY Study Group. 2014. Alterations in Left Ventricular, Left Atrial, and Right Ventricular Structure and Function to Cardiovascular Risk Factors in Adolescents with Type 2 Diabetes Participating in the TODAY Clinical Trial. Pediatr. Diabetes. In press. 10.1111/pedi.12119. 24450390.
148. Tremblay M.S. Warburton D.E.R. Janssen I. Paterson D.H. Latimer A.E. Rhodes R.E. et al 2011. New Canadian Physical Activity Guidelines. Appl. Physiol. Nutr. Metab. 36 (1): 36-46. 10.1139/H11-009. 21326376.
149. Turer A.T. Scherer P.E. 2012. Adiponectin: Mechanistic Insights and Clinical Implications. Diabetologia, 55 (9): 2319-2326. 10.1007/s00125-012-2598-x. 22688349.
150. Turrens J.F. 2003. Mitochondrial Formation of Reactive Oxygen Species. J. Physiol. 552 (2): 335-344. 10.1113/jphysiol.2003.049478. 14561818.
151. Urbina E.M. Kimball T.R. McCoy C.E. Khoury P.R. Daniels S.R. Dolan L.M. 2009. Youth With Obesity and Obesity-Related Type 2 Diabetes Mellitus Demonstrate Abnormalities in Carotid Structure and Function. Circulation, 119 (22): 2913-2919. 10.1161/CIRCULATIONAHA.108.830380. 19470890.
152. Utsal L. Tillmann V. Zilmer M. Mäestu J. Purge P. Jürimäe J. et al 2012. Elevated Serum IL-6, IL-8, MCP-1, CRP, and IFN-Î" Levels in 10-to 11-Year-Old Boys with Increased BMI. Horm. Res. Paediatr. 78 (1): 31-39. 10.1159/000339831. 22832157.
153. Uysal K.T. Wiesbrock S.M. Marino M.W. Hotamisligil G.S. 1997. Protection from Obesity-Induced Insulin Resistance in Mice Lacking TNF-Alpha Function. Nature, 389 (6651): 610-614. 10.1038/39335. 9335502.
154. Vanderloo S.E. Johnson J.A. Reimer K. McCrea P. Nuernberger K. Krueger H. et al 2012. Validation of Classification Algorithms for Childhood Diabetes Identified from Administrative Data. Pediatr. Diabetes, 13 (3): 229-234. 10.1111/j.1399-5448.2011.00795.x. 21771232.
155. Voisin S. Almén M.S. Moschonis G. Chrousos G.P. Manios Y. Schiöth H.B. 2014. Dietary Fat Quality Impacts Genome-Wide DNA Methylation Patterns in a Cross-Sectional Study of Greek Preadolescents. Eur. J. Hum. Genet. In press. 10.1038/ejhg.2014.139. 25074463.
156. Wadwa R.P. Urbina E.M. Anderson A.M. Hamman R.F. Dolan L.M. Rodriguez B.L. et al 2010. Measures of Arterial Stiffness in Youth With Type 1 and Type 2 Diabetes The SEARCH for Diabetes in Youth Study. Diabetes Care, 33 (4): 881-886. 10.2337/dc09-0747. 20067960.
157. Watts K. Beye P. Siafarikas A. Davis E.A. Jones T.W. O'Driscoll G. Green D.J. 2004. Exercise Training Normalizes Vascular Dysfunction and Improves Central Adiposity in Obese Adolescents. J. Am. Coll. Cardiol. 43 (10): 1823-1827. 10.1016/j.jacc.2004.01.032. 15145107.
158. Weiss R. Dufour S. Taksali S.E. Tamborlane W.V. Petersen K.F. Bonadonna R.C. et al 2003. Prediabetes in Obese Youth: A Syndrome of Impaired Glucose Tolerance, Severe Insulin Resistance, and Altered Myocellular and Abdominal Fat Partitioning. Lancet, 362 (9388): 951-957. 10.1016/S0140-6736(03)14364-4. 14511928.
159. Weiss R. Dziura J. Burgert T.S. Tamborlane W.V. Taksali S.E. Yeckel C.W. et al 2004. Obesity and the Metabolic Syndrome in Children and Adolescents. N. Engl. J. Med. 350 (23): 2362-2374. 10.1056/NEJMoa031049. 15175438.
160. Weiss R. Caprio S. Trombetta M. Taksali S.E. Tamborlane W.V. Bonadonna R. 2005. Beta-Cell Function across the Spectrum of Glucose Tolerance in Obese Youth. Diabetes, 54 (6): 1735-1743. 10.2337/diabetes.54.6.1735. 15919795.
161. West N.A. Crume T.L. Maligie M.A. Dabelea D. 2011. Cardiovascular Risk Factors in Children Exposed to Maternal Diabetes in Utero. Diabetologia. 54 (3): 504-507. 10.1007/s00125-010-2008-1. 21153896.
162. Whalley G.A. Gusso S. Hofman P. Cutfield W. Poppe K.K. Doughty R.N. Baldi J.C. 2009. Structural and Functional Cardiac Abnormalities in Adolescent Girls with Poorly Controlled Type 2 Diabetes. Diabetes Care, 32 (5): 883-888. 10.2337/dc08-2005. 19196881.
163. White M.F. 1997. The Insulin Signalling System and the IRS Proteins. Diabetologia, 40 (2): S2-S17. 10.1007/s001250051387. 9248696.
164. White N.H. Cleary P.A. Dahms W. Goldstein D. Malone J. Tamborlane W.V.; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. 2001. Beneficial Effects of Intensive Therapy of Diabetes during Adolescence: Outcomes after the Conclusion of the Diabetes Control and Complications Trial (DCCT). J. Pediatr. 139 (6): 804-812. 10.1067/mpd.2001.118887. 11743505.
165. Wicklow B.A. Sellers E.A.C. 2014. Maternal Health Issues and Cardio-Metabolic Outcomes in the Offspring: A Focus on Indigenous Populations. Best Pract. Res. Clin. Obstet. Gynaecol. In press. 10.1016/j.bpobgyn.2014.04.017. 25238683.
166. Wicklow B.A. Wittmeier K.D.M. MacIntosh A.C. Sellers E.A.C. Ryner L. Serrai H. Dean H.J. McGavock J.M. 2012. Metabolic Consequences of Hepatic Steatosis in Overweight and Obese Adolescents. Diabetes Care 35 (4): 905-910. 10.2337/dc11-1754. 22357180.
167. Willi S.M. Martin K. Datko F.M. Brant B.P. 2004. Treatment of Type 2 Diabetes in Childhood Using a Very-Low-Calorie Diet. Diabetes Care, 27 (2): 348-353. 10.2337/diacare.27.2.348. 14747212.
168. Wittmeier K.D.M. Wicklow B.A. MacIntosh A.C. Sellers E.A.C. Ryner L.N. Serrai H. et al 2012 a. Hepatic Steatosis and Low Cardiorespiratory Fitness in Youth with Type 2 Diabetes. Obesity (Silver Spring), 20 (5): 1034-1040. 10.1038/oby.2011.379. 22222927.
169. Wittmeier K.D.M. Wicklow B.A. Sellers E.A.C. Griffith A.T.R. Dean H.J. McCavock J.M. 2012 b. Success with Lifestyle Monotherapy in Youth with New-Onset Type 2 Diabetes. Paediatr. Child Health, 17 (3): 129-132. 23449816.
170. Wronkowitz N. Romacho T. Sell H. Eckel J. 2014. Adipose Tissue Dysfunction and Inflammation in Cardiovascular Disease. Front. Horm. Res. 43: 79-92. 10.1159/000360560. 24943300.
171. Yang B.T. Dayeh T.A. Volkov P.A. Kirkpatrick C.L. Malmgren S. Jing X. et al 2012. Increased DNA Methylation and Decreased Expression of PDX-1 in Pancreatic Islets from Patients with Type 2 Diabetes. Mol. Endocrinol. 26 (7): 1203-1212. 10.1210/me.2012-1004. 22570331.
172. Youssef H. Groussard C. Pincemail J. Moussa E. Jacob C. Lemoine S. et al 2009. Exercise-Induced Oxidative Stress in Overweight Adolescent Girls: Roles of Basal Insulin Resistance and Inflammation and Oxygen Overconsumption. Int. J. Obes. 33 (4): 447-455. 10.1038/ijo.2009.49. 19363498.
173. Zampetaki A. Kiechl S. Drozdov I. Willeit P. Mayr U. Prokopi M. et al 2010. Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes. Circ. Res. 107 (6): 810-817. 10.1161/CIRCRESAHA.110.226357. 20651284.
174. Zhang J.-M. An J. 2007. Cytokines, Inflammation and Pain. Int. Anesthesiol. Clin. 45 (2): 27-37. 10.1097/AIA.0b013e318034194e. 17426506.